🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, asserting the firms withheld potential risks that the drug presented to pediatric cognitive development.

The lawsuit arrives a month after Donald Trump publicized an unverified association between using acetaminophen - referred to as paracetamol - throughout gestation and autism in offspring.

The attorney general is suing J&J, which previously sold the medication, the exclusive pain medication recommended for expectant mothers, and Kenvue, which now manufacturers it.

In a statement, he stated they "misled consumers by making money from suffering and promoting medication ignoring the risks."

Kenvue asserts there is lacking scientific proof linking Tylenol to autism.

"These manufacturers deceived for years, deliberately risking numerous people to boost earnings," Paxton, from the Republican party, stated.

The company stated officially that it was "very worried by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its official site, Kenvue also stated it had "regularly reviewed the applicable studies and there is insufficient valid information that indicates a established connection between consuming paracetamol and autism spectrum disorder."

Organizations representing physicians and healthcare providers agree.

The leading OB-GYN organization has stated paracetamol - the primary component in acetaminophen - is one of the few options for expectant mothers to address discomfort and fever, which can pose major wellness concerns if left untreated.

"In multiple decades of studies on the utilization of acetaminophen in gestation, no reliable research has conclusively proven that the use of acetaminophen in any trimester of gestation results in brain development issues in young ones," the organization stated.

This legal action references recent announcements from the previous government in arguing the drug is reportedly hazardous.

Last month, Trump generated worry from medical authorities when he told women during pregnancy to "fight like hell" not to take Tylenol when ill.

The FDA then released a statement that doctors should consider limiting the use of Tylenol, while also stating that "a causal relationship" between the drug and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who manages the FDA, had promised in spring to conduct "comprehensive study program" that would determine the cause of autism spectrum disorder in a limited time.

But experts advised that identifying a single cause of autism - thought by researchers to be the outcome of a complex mix of inherited and environmental factors - would be difficult.

Autism is a form of enduring cognitive variation and disability that affects how persons perceive and relate to the world, and is recognized using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is running for US Senate - alleges the manufacturer and J&J "intentionally overlooked and sought to suppress the research" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the corporations "remove any commercial messaging" that asserts acetaminophen is reliable for expectant mothers.

This legal action mirrors the complaints of a collection of mothers and fathers of minors with autism and ADHD who filed suit against the manufacturers of acetaminophen in recently.

A federal judge dismissed the case, stating research from the family's specialists was inconclusive.